Abstract
Idiopathic thrombocytopenic purpura (ITP) occurs more commonly in young women during the reproductive years. To obtain information for management of ITP in pregnancy, we performed a nationwide retrospective survey. Findings from a total of 284 pregnant women with ITP and their 286 newborn infants were available for analysis. The bleeding tendency at delivery was managed chiefly with corticosteroid, intravenous high-dose γulin, and platelet transfusion. Maternal complications occurred in 77 cases (27.1%) and were frequently seen in cases with poor control of ITP. Neonatal abnormalities, which were not influenced by the clinical state of the mother, occurred at a frequency of 17.8%. Thrombocytopenia in neonates occurred in 48 cases (22.4%), and bleeding tendency was found in 16 cases (6.3%) without severe bleeding. Prediction of thrombocytopenia in neonates was difficult. However, infants from splenectomized mothers with well-controlled ITP showed thrombocytopenia more frequently than those from nonsplenectomized mothers. Mothers treated with steroids at doses greater than 15 mg/day showed a high frequency of maternal complications and fetal abnormal body weight. These observations will be useful in the management of pregnant women with ITP and their infants.
Similar content being viewed by others
References
George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods or the American Society of Hematology.Blood. 1996;88:3–40.
Cook RL, Miller RC, Katz VL, Cefalo RC. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management.Obstet Gynecol. 1991;78:578–583.
Iyori H, Fujisawa K, Akatsuka J. Thrombocytopenia in neonates born to women with autoimmune thrombocytopenic purpura.Pediatric Hematol Oncol. 1997;14:367–373.
Tampakoudis P, Bili H, Lazaridis E, Anastasiadou E, Andreou A, Mantalenakins S. Prenatal diagnosis of intracranial hemorrhage secondary to maternal idiopathic thrombocytopenic purpura: a case report.Am J Perinatol. 1995;12:268–270.
Kelton JG. Thrombocytopenia in pregnancy. In: Schechter G P, Hoffman R, Schrirer SL, eds.Hematology 1999: American Society of Hematology Education Program Book. Washington, DC:American Society of Hematology; 1999:490–497.
Gill KK, Kelton JG. Management of idiopathic thrombocytopenic purpura in pregnancy.Semin Hematol. 2000;37:275–289.
Kaplan C, Daffos F, Forestier F, et al. Fetal platelet counts in thrombocytopenic pregnancy.Lancet. 1990;336:979–982.
Scioscia AL, Grannum PA, Copel JA, Hobbins JC. The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura.Am J Obstet Gynecol. 1988;159:1066–1068.
Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases.Am J Obstet Gynecol. 1985;153: 655–660.
Letsky EA, Greaves M. Guideline: guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia.Br J Haematol. 1996;95:21–26.
Kelton JG. Management of the pregnant patient with idiopathic thrombocytopenic purpura.Ann Intern Med. 1983;99:796–800.
Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries.Am J Obstet Gynecol. 1990;162: 731–734.
McCrae KR, Samuels P, Schreiber AD. Pregnancy-associated thrombocytopenia: pathogenesis and management.Blood. 1992;80: 2697–2714.
Aster RH. “Gestational”rombocytopenia: a plea for conservative management.N Engl J Med. 1990;323:264–266.
Hohlfeld P, Forestier F, Kaplan C, Tissot JD, Daffos F. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings.Blood. 1994;84:1851–1856.
Ostesen M. Optimisation of antirheumatic drug treatment in pregnancy.Clin Pharmacokinet. 1994;27:486–503.
Sainio S, Joutsi L, Jarvenpaa AL, et al. Idiopathic thrombocy-topenic purpura in pregnancy.Acta Obstet Gynecol Scand. 1998;77: 272–277.
Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia.N Engl J Med. 1993;329:1463–1466.
Samuels P, Bussel JB, Braitman LE, et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura.N Engl J Med. 1990; 323:229–235.
Valat AS, Caulier MT, Devos P, et al. Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia.Br J Haematol. 1998;103:397–401.
Sharon R, Tatarsky I. Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura.Am J Hematol. 1994;46:87–90.
Yamada H, Kato EH, Kobashi G, et al. Passive immune thrombocytopenia in neonates of mothers with idiopathic thrombocytopenic purpura: incidence and risk factors.Semin Thromb Hemost. 1999;25:491–496.
Tchernia G, Morel-Kopp MC, Yvart J, Kaplan C. Neonatal thrombocytopenia and hidden maternal autoimmunity.Br J Haematol. 1993;84:457–463.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Fujimura, K., Harada, Y., Fujimoto, T. et al. Nationwide Study of Idiopathic Thrombocytopenic Purpura in Pregnant Women and the Clinical Influence on Neonates. Int J Hematol 75, 426–433 (2002). https://doi.org/10.1007/BF02982137
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02982137